Profiel
Andreas Maetzel served as Vice President-Global Medical Affairs at BioCryst Pharmaceuticals, Inc. from 2014 to 2017.
Prior to that, he was VP-Clinical Development & Regulatory Affairs at Cornerstone Therapeutics, Inc. from 2013 to 2014.
He also worked as Senior Vice President-Medical at KalVista Pharmaceuticals, Inc. Dr. Maetzel holds a graduate and doctorate degree from the University of Toronto and a doctorate degree from the University of Hannover.
Eerdere bekende functies van Andreas Maetzel
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-02-2017 |
| CORNERSTONE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-02-2014 |
| KALVISTA PHARMA | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Andreas Maetzel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hannover
University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornerstone Therapeutics, Inc.
Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for hospital and specialty care areas including respiratory, rare diseases & critical care | Health Technology |
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
















